Journal of Translational Medicine

Scope & Guideline

Bridging Discovery and Healing.

Introduction

Delve into the academic richness of Journal of Translational Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJ TRANSL MED / J. Transl. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Translational Medicine aims to bridge the gap between laboratory research and clinical practice by publishing innovative studies that advance our understanding of disease mechanisms and therapeutic approaches. The journal encompasses a broad range of topics related to translational medicine, emphasizing the importance of interdisciplinary collaboration in medicine and healthcare.
  1. Translational Research:
    Focuses on studies that translate basic biological research into clinical applications, including the development of new therapies and diagnostic tools.
  2. Cancer Biology and Therapy:
    Includes research on the molecular mechanisms underlying cancer, the tumor microenvironment, and novel therapeutic strategies, including immunotherapy and targeted therapy.
  3. Microbiome and Metabolism:
    Explores the role of the microbiome in health and disease, particularly its impact on metabolic processes and disease outcomes.
  4. Genomics and Precision Medicine:
    Investigates the genetic basis of diseases and the application of genomics in personalizing treatment strategies for patients.
  5. Immunology and Inflammation:
    Covers research on immune responses in various diseases, including autoimmune disorders, cancer, and infectious diseases.
  6. Stem Cell and Regenerative Medicine:
    Focuses on the use of stem cells and regenerative therapies to repair and regenerate damaged tissues.
  7. Clinical Trials and Epidemiology:
    Reports on clinical trials, epidemiological studies, and public health research that inform evidence-based medical practice.
The Journal of Translational Medicine is currently witnessing several emerging trends that reflect the evolving landscape of biomedical research. These trends highlight the integration of technology and novel methodologies in understanding complex diseases and improving patient outcomes.
  1. Artificial Intelligence in Medicine:
    The integration of AI and machine learning in diagnostics, treatment predictions, and personalized medicine is gaining momentum, with numerous studies exploring its application in various disease contexts.
  2. Microbiome Research:
    The relationship between the microbiome and various health conditions, particularly its role in cancer and metabolic diseases, is becoming increasingly prominent in current literature.
  3. Liquid Biopsy Development:
    Research focusing on non-invasive liquid biopsies for cancer detection and monitoring is expanding, reflecting a shift towards patient-friendly diagnostic techniques.
  4. Immunotherapy Advancements:
    Studies on novel immunotherapies, including CAR-T cell therapy and immune checkpoint inhibitors, are on the rise, reflecting their growing importance in cancer treatment.
  5. Regenerative Medicine and Tissue Engineering:
    Innovative approaches in regenerative medicine, particularly the use of stem cells and bioengineered tissues, are trending, driven by advancements in technology and understanding of cellular mechanisms.
  6. Integrative Omics Approaches:
    Research combining genomics, proteomics, metabolomics, and transcriptomics to provide a holistic view of diseases is becoming more common, emphasizing the need for multi-faceted research strategies.
  7. Health Disparities and Social Determinants of Health:
    Increasing attention is being given to the impact of social determinants on health outcomes, with studies investigating disparities in access to healthcare and treatment efficacy.

Declining or Waning

Over recent years, certain themes within the Journal of Translational Medicine have seen a decline in focus, possibly reflecting shifts in research priorities or advancements in understanding that have reduced the novelty of these topics.
  1. Traditional Drug Discovery Methods:
    As the field of drug discovery evolves with the advent of high-throughput screening and computational methods, traditional approaches are becoming less emphasized in favor of more innovative strategies.
  2. Basic Laboratory Techniques:
    While foundational, there has been a noticeable shift towards more complex and sophisticated techniques in translational research, leading to a decline in papers focused solely on basic laboratory methods.
  3. Invasive Diagnostic Procedures:
    With the rise of non-invasive techniques and liquid biopsies, there has been a reduction in the publication of studies centered around traditional invasive diagnostic methods.
  4. Animal Models in Early Research:
    As the field moves towards more human-relevant models and in vitro systems, studies relying heavily on animal models are becoming less prevalent.
  5. Single-Pathway Studies:
    Research focusing on single signaling pathways is waning, with a growing interest in multi-pathway and systems biology approaches that reflect the complexity of biological systems.

Similar Journals

EXPERIMENTAL AND MOLECULAR MEDICINE

Unraveling the complexities of health and disease.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

Cancer Communications

Connecting Researchers, Practitioners, and Patients in Oncology
Publisher: WILEYISSN: Frequency: 12 issues/year

Cancer Communications, published by WILEY, is a leading open-access journal that has positioned itself at the forefront of cancer research and oncology since its inception in 2017. With an impressive HIndex reflective of its scholarly impact and recognized in the Q1 category for both Cancer Research and Oncology as of 2023, this journal consistently ranks in the top echelons of its field, specifically at Rank #16/404 and Rank #13/230 in their respective categories on Scopus. Cancer Communications aims to disseminate cutting-edge research findings, innovative methodologies, and significant advancements in cancer treatments, thereby fostering a deeper understanding of oncology among researchers, healthcare professionals, and students. The journal operates under an Open Access model since 2018, ensuring that vital research is accessible to a global audience, thus enhancing collaboration and knowledge sharing necessary to tackle one of the most pressing health challenges of our time. Located in Hoboken, NJ, United States, and with a strong commitment to scientific excellence, Cancer Communications remains an essential resource for anyone engaged in the fight against cancer.

Biomolecules and Biomedicine

Fostering Collaboration in Molecular Biology and Medicine
Publisher: ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVOISSN: 2831-0896Frequency: 6 issues/year

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

FASEB JOURNAL

Pioneering Insights in Biochemistry, Genetics, and Medicine
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

MedComm

Discovering Tomorrow's Breakthroughs Today
Publisher: WILEYISSN: Frequency: 4 issues/year

MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.

Cancer Biology & Medicine

Elevating the Standards of Cancer Biology
Publisher: CHINA ANTI-CANCER ASSOCISSN: 2095-3941Frequency: 4 issues/year

Cancer Biology & Medicine is a distinguished Open Access journal published by the China Anti-Cancer Association, dedicated to advancing research and understanding in the fields of Cancer Research and Oncology. Since its inception in 2012, the journal has provided a vital platform for the dissemination of high-quality research, evidenced by its impressive ranking within the Q1 and Q2 categories of oncology and cancer research as of 2023. With a significant impact factor and a Scopus ranking of #64 in Medicine/Oncology and #55 in Biochemistry, Genetics, and Molecular Biology, it plays a crucial role in shaping the future of cancer biology. By offering open access to its content, the journal ensures that pivotal research findings are readily available to researchers, professionals, and students globally, thereby fostering collaboration and innovation in cancer research. Situated in Tianjin, China, this journal is poised at the frontier of oncology research, making a significant impact through its rigorous peer-reviewed articles that address critical challenges in the field.

Blood Science

Connecting Researchers to Breakthroughs in Hematology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2543-6368Frequency:

Blood Science is a distinguished peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamic field of hematology. Since its inception, the journal has aimed to disseminate high-quality research and innovative findings that contribute to our understanding of blood-related health issues. With the ISSN 2543-6368, it offers a platform for academic discussions and breakthroughs in various subfields including hematopathology, blood disorders, and transfusion medicine. As of 2023, Blood Science is ranked in the third quartile (Q3) within the hematology category, indicating a burgeoning influence among its peers, with a Scopus rank of #101 out of 137 journals, placing it in the 26th percentile. Although it is not an open-access journal, it provides essential insights and valuable data for researchers, healthcare professionals, and students alike, enhancing the collective knowledge and practices in hematology. With a publication period spanning from 2019 to 2024, Blood Science remains committed to fostering the advancement of blood science research and enhancing patient care methodologies.

Current Research in Translational Medicine

Fostering Collaboration in Cutting-Edge Medical Research
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 2452-3186Frequency: 4 issues/year

Current Research in Translational Medicine, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, is a dynamic open-access journal that has been at the forefront of innovative research since its inception in 2016. With a strong commitment to advancing the fields of biochemistry, hematology, infectious diseases, oncology, and transplantation, the journal provides an invaluable platform for researchers and practitioners to share novel findings that bridge laboratory discoveries and clinical applications. Currently recognized in prestigious categories such as Q1 and Q2 quartiles, this journal emphasizes the importance of translational science in improving health outcomes, supported by a rigorous editorial process and a commitment to high-quality research dissemination. Being listed in reputable databases like Scopus, it enables authors to reach a wide audience, ensuring that their impactful work contributes to the global dialogue on critical medical advancements. With its open access model, Current Research in Translational Medicine encourages widespread collaboration and engagement among the scientific community, solidifying its role as a leading journal in medicine and related fields.

JOURNAL OF EXPERIMENTAL MEDICINE

Elevating Experimental Medicine to New Heights
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

Journal of Biomedical Research

Elevating Biomedical Research Through Rigorous Scholarship
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.